“Current revenue scale is $1.3 billion. We anticipate it will grow to $5 billion, just in five years’ time. We’ve committed to invest about two-thirds of Fujifilm’s entire annual capex in this business.” Toshihisa “Toshi” Iida, Chairman of FUJIFILM Biotechnologies
How Digital Is Your CDMO? Take this quick 5 minute assessment to benchmark your organization’s Digital and AI maturity — and see how you compare with industry peers.
At CDMO Live 2025 a panel of M&A advisors and consultants explored how private equity investment has transformed the contract manufacturing sector, whilst examining current challenges from geopolitical uncertainty to market volatility. The session, sponsored by TH Healthcare & Life
The biologics external manufacturing panel at CDMO Live 2025, sponsored by BSP Pharmaceuticals, brought together industry leaders to tackle the key challenges in scaling biological manufacturing amid geopolitical tensions, capacity constraints and evolving partnership models. The panel featured Olaf Birkenmeier,
At CDMO Live 2025, Elisabeth Stampa (Medicines for Europe), Elena Barboni (Flamma) and Agneta Larhed (RegSmart Life Science) discussed how Europe’s stringent new regulations could reshape the continent’s pharmaceutical manufacturing landscape. Europe’s pharmaceutical manufacturing sector faces an unprecedented challenge as
According to epidemiologist Dr. Katelyn Jetelina, the United States could be experiencing its most significant disruption to vaccine policy in 70 years, with anti-vaccine advocates now controlling federal vaccine recommendations for 330 million Americans. This assessment comes from Dr. Jetelina,
The COVID-19 pandemic fundamentally changed pharmaceutical manufacturing approaches – demonstrating it’s possible to dramatically compress traditional timelines while maintaining quality standards. At CDMO Live 2025, Fabrice Le Garrec, founder of the OSICS network, shared lessons learned from his experience during
“When you’re building something at the edge of science, it’s crucial to start with the problem, not the solution. My team has created 15 pharma startups using this approach, and 14 are still alive.” – Kerstin Papenfuss, Director of Pharma
The escalating military conflict between Israel and Iran has reached a critical juncture, with Iran’s parliament voting to close the Strait of Hormuz in response to U.S. military actions on 22nd June 2025. This potential closure of the world’s most
“This enterprise is lacking congressional support. The host of prior leaders in this policy space have left,” warn biodefense advocates pushing for renewed bipartisan commitment Jennifer Alton, President of Pathway Policy Group, delivered this stark assessment during a biodefense policy
